Emmanuel Griessinger
Griessinger, Emmanuel, 1978-....
VIAF ID: 208267407 (Personal)
Permalink: http://viaf.org/viaf/208267407
Preferred Forms
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation | |
Acute myeloid leukemia xenograft success prediction: Saving time. | |
Aerodynamically assisted bio-jetting of hematopoietic stem cells | |
APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts | |
BCL-B | |
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice | |
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells | |
Évaluation préclinique du potentiel thérapeutique d'un inhibiteur de IKK2 et de FLT3 dans le traitement des leucémies aiguës myéloïdes | |
[Fighting cancer via NF-kappa B inhibition] | |
Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients. | |
Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation | |
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction | |
"Microenvironmental contaminations" induced by fluorescent lipophilic dyes used for noninvasive in vitro and in vivo cell tracking | |
A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms | |
Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis. | |
Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas | |
Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells. | |
Preclinical study and therapeutic potential of a dual inhibitor of IKK2 and FLT3 for AML treatment. | |
Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy | |
A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia. | |
L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia | |
β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells |